Assessment of the Oxidative Status in Children with Type 1 Diabetes Mellitus

Bykov Yu. V.
MD, PhD, Assistant, Chair for Anesthesiology, Resuscitation and Emergency Medicine¹

Baturin V. A.
Doctor of Medicine, Professor, Head, Chair for Clinical Pharmacology¹

Vorobyeva A. P.
MD, Anesthesiologist-Resuscitator²

Vartanyan A. A.
MD, Junior Researcher, м.н.с., Laboratory of Pharmacology of the Center for Morphology, Pharmacology and Biotechnology; Resident Physician, Chair for Clinical Laboratory Diagnostics¹

1 - Stavropol State Medical University, 355017, Stavropol, Russian Federation
2 - G.K. Filippsky City Children's Clinical Hospital, Stavropol, Russian Federation

Vorobyova Anna; e-mail: a.v.955@yandex.ru.

None declared.

The study had no sponsorship.

Background. Type 1 diabetes mellitus (DM) is one of the most prevalent chronic diseases in children. Oxidative stress (OS) plays an important role in the development of diabetes and its complications. Aim of the study. To analyze markers of OS in children with newly diagnosed and chronic course of type 1 DM. Materials and methods. The study included 73 children aged 3 to 17 years. The study group consisted of 49 patients with type 1 DM, the control group included 24 children (apparently healthy children). The study group was split into 2 subgroups depending on the duration of the disease: 1 subgroup – children with newly diagnosed type 1 DM, 2 subgroup – children with a chronic course of DM. All children had their blood sampled to assess the following OS markers: 8-Oxo-2'-deoxyguanosine (8-OHdG; Pg/ml); 8-isoprostane (8 IS; Pg/ml); malondialdehyde (MDA; Ng/ml); advanced oxidation protein products (AOPPx10; Ng/ml). Statistical processing of data involved the use of the Mann–Whitney U test and the Kruskal–Wallis test. Results. Significant differences in the average values of OS markers between patients with type 1 DM and control group were revealed. The average levels of 8 IS – 89.53 [81.96-106.4] Pg/ml were significantly higher in the study group, compared with the control – 78.21500 [65.235-88.135] Pg/ml (p=0.0006), as were the average levels of 8-OHdG – 480.3 [413.8000-560.3000] Pg/ml in the study group; 417,9000 [361,7500-460.7] Pg/ml – in the control group (p=0.01). The maximum values were found in the levels of 8 IS and 8-OHdG, in the group of children with chronic type 1 diabetes: 510.1 [440.9-594.4] Pg/ml (p =0.0053) for 8-OHdG and 95.59 [86.32-197.5] Pg/ml (p=0.0001) for 8 IS. The average levels of MDA and AOPP did not show significant differences between the study and the control groups. Conclusion. Patients with type 1 DM have distinct manifestations of OS. These manifestations are most pronounced in the group of patients with chronic type 1 DM.

type 1 diabetes mellitus, oxidative stress, children and adolescents, isoprostane, malondialdehyde

10.29234/2308-9113-2022-10-4-31-41

1. Saxby N., Beggs S., Kariyawasam N., Battersby M., Lawn S. Do guidelines provide evidence-based guidance to health professionals on promoting developmentally appropriate chronic condition self-management in children? A systematic review. Chronic Illn 2020; 16(4): 239-252.

2. Selvin E., Juraschek S., Diabetes epidemiology in the COVID-19 pandemic. Diabetes Care 2020; 43(8) :1690-1694, doi: 10.2337/dc20-1295

3. International Diabetes Federation. IDF Diabetes Atlas. 7th Edition, 2015. Available at: www.diabetesatlas.org

4. Harding J.L., Pavkov M.E,. Magliano D.J., Shaw J.E., Gregg E.W. Global trends in diabetes complications: a review of current evidence. Diabetologia 2019; 62(1): 3-16, doi: 10.1007/s00125- 018-4711-2

5. Kostopoulou E., Livada I., Partsalaki I., Lamari F., Skiadopoulos S., Rojas Gil A.P., Spiliotis B.E. The role of carbohydrate counting in glycemic control and oxidative stress in patients with type 1 diabetes mellitus (T1DM). Hormones (Athens) 2020; 19(3): 433-438, doi: 10.1007/s42000-020-00189-8

6. Bigagli E., Lodovici M. Circulating oxidative stress biomarkers in clinical studies on type 2 diabetes and its complications. Oxid Med Cell Longev 2019; 12:5953685, doi: 10.1155/2019/5953685

7. Ighodaro O.M. Molecular pathways associated with oxidative stress in diabetes mellitus. Biomed. Pharmacother 2018; 108: 656-662, doi: 10.1016/j.biopha.2018.09.058

8. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006; 52: 601-623.

9. Moussa S. Oxidative stress in diabetes mellitus. Romanian J. Biophys 2008; 18: 225-236.

10. Colomo N., López-Siguero J.P., Leiva I., Fuentes N., Rubio-Martín E., Omiste A., Guerrero M., Tapia M.J., Martín-Tejedor B., Ruiz de Adana M.S., Olveira G. Relationship between glucose control, glycemic variability, and oxidative stress in children with type 1 diabetes. Endocrinol Diabetes Nutr 2019; 66(9): 540-549. 

11. Tuzgen S., Hanimoglu H., Tanriverdi T. Relationship between DNA damage and total antioxidant capacity in patients with glioblastoma multiforme. Clin Oncol 2007; 19: 177-181.

12. Selmeci L., Szekely M., Soos P., Seres L., Klinga N., Geiger A., Acsady G. Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels. Free Radic Res 2006, 40: 952-958.

13. Voller A., Bartlett A., Bidwell D.E. Enzyme immunoassays with special reference to ELISA techniques. J. Clin. Pathol. 1978; 31(6): 507–520, doi: 10.1136/jcp.31.6.507

14. Pękala-Wojciechowska A., Poznański M., Szyszow K., Antczak A. Concentration of 8-isoprostanes in the exhaled breath condensate as a marker of oxidative stress in patients with type 1 diabetes. Adv Respir Med 2018; 86(1): 3-6, doi: 10.5603/ARM.2018.0002

15. Flores L., Rodela S., Abian J., Clària J., Esmatjes E. F2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control. Metabolism 2004; 53(9): 1118-20, doi: 10.1016/j.metabol.2004.04.005

16. Sanchez M., Roussel R., Hadjadj S., Moutairou A., Marre M., Velho G., Mohammedi K. Plasma concentrations of 8-hydroxy-2'-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes. Diabetologia 2018; 61(4): 977-984, doi: 10.1007/s00125-017-4510-1

17. Soliman A., Awad E., Abdelghffar A., Emara I. Assessment of 8-Hydroxy-2-Deoxyguanosine (8-OHdG) as a Diagnostic Marker for Diabetic Nephropathy in Type 1 Egyptian Diabetic Patients. Journal of Diabetes & Metabolism 2019; 10(4), doi: 10.35248/2155-6156.19.10.826

18. Firoozrai M., Nourbakhsh M., Razzaghy-Azar M. Erythrocyte susceptibility to oxidative stress and antioxidant status in patients with type 1 diabetes. Diabetes Res Clin Pract 2007; 77(3): 427-32, doi: 10.1016/j.diabres.2007.02.001

19. Kostopoulou E., Kalaitzopoulou E., Papadea P., Skipitari M., Gil A.P., Spiliotis B.E., Georgiou C.D. Oxidized lipid-associated protein damage in children and adolescents with type 1 diabetes mellitus: New diagnostic/prognostic clinical markers. Pediatr Diabetes 2021; 22(8): 1135-1142, doi: 10.1111/pedi.13271

20. Reis J.S., Veloso C.A., Volpe C.M., Fernandes J.S., Borges E.A., Isoni C.A., Dos Anjos P.M., Nogueira-Machado J.A. Soluble RAGE and malondialdehyde in type 1 diabetes patients without chronic complications during the course of the disease. Diab Vasc Dis Res 2012; 9(4): 309-14, doi: 10.1177/1479164111436316

21. Conti G., Caccamo D., Siligato R., Gembillo G, Satta E., Pazzano D., Carucci N., Carella A., Del Campo G., Salvo A., Santoro D. Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy. Medicina 2019; 55(10): 675, doi: 10.3390/medicina55100675

22. Shi X., Hou F., Niu H., Wang G., Xie D., Guo Z., Zhou Z., Yang F., Tian J., Zhang X. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology 2008; 149(4): 1829-39, doi: 10.1210/en.2007-1544

23. Domínguez С., Ruiz E., Gussinye M., Carrascosa A. Oxidative Stress at Onset and in Early Stages of Type 1 Diabetes in Children and Adolescents. Diabetes Care 1998; 21(10): 1736-1742.